Closed System Drug Transfer Devices

Wednesday, December 6, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Interest in closed system drug transfer devices has been growing as regulatory activity

and practitioner awareness surrounding hazardous drug compounding and administration continue to increase. Drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more
clearly understood.

Read the full report: https://www.reportlinker.com/p02317746

For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that – in spite of promising new drugs based on therapeutic antibodies – continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers.

Regulatory and industry efforts to create standards and procedures for closed system drug transfer devices are designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. This report analyzes devices, regulations, markets and participants competing in the closed system drug transfer device segment and provides insight, analysis, assessments and forecasts to assist readers in navigating this rapidly evolving sector.

What You Will Learn• What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?• What are the major therapeutic demand drivers for cytotoxic drug therapeutics?• What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?• What is the market share and product position in the market and what will it look like in 2022?• Who are the companies behind the current generation of cytotoxic transfer devices and what are their business models?• What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging closed system drug transfer devices?• What is the impact of economic, technology, and regulatory factors on CSDT device demand?

Read the full report: https://www.reportlinker.com/p02317746

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Contact Clare: [email protected] US: (339)-368-6001  Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/closed-system-drug-transfer-devices-300567398.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store